Loading insider details...
Latest Form 4 (Aug 20, 2026): Sale of 101 ACRV shares, $203.01.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 20, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Sale | 101 | $203.01 |
| May 20, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Grant/Award | 14,227 | n/a |
| May 18, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 99 | $190.08 |
| Mar 3, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Grant/Award | 31,900 | n/a |
| Feb 18, 2026 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 116 | $189.08 |
| Nov 18, 2025 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 99 | $221.76 |
| Aug 18, 2025 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 99 | $137.61 |
| May 16, 2025 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 99 | $112.86 |
| Mar 4, 2025 | Acrivon Therapeutics, Inc. (ACRV) | Grant/Award | 31,900 | n/a |
| Feb 19, 2025 | Acrivon Therapeutics, Inc. (ACRV) | Tax Withholding | 116 | $628.72 |